Category: 3468-17-5

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.3468-17-5,(1H-Indol-6-yl)methanamine,as a common compound, the synthetic route is as follows.

General procedure: To solutions of 2-(2,4-dichlorophenoxy)propanoic acid (100 mg,0.43 mmol) in DMF (2 mL) were added 2-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU; 200 mg,0.53 mmol), the corresponding benzylamines (0.50 mmol), anddiisopropylethylamine (100 lL, 0.57 mmol). The resulting mixtureswere stirred at room temperature for 16 h, then poured intowater (20 mL). The aqueous mixtures were then stirred at roomtemperature until solids precipitate. The solids were filtered,rinsed with water, and dried to provide solids that were recrystallizedfrom CH2Cl2/hexane to provide the products 34a-y.

3468-17-5, 3468-17-5 (1H-Indol-6-yl)methanamine 17221101, aindole-building-block compound, is more and more widely used in various fields.

Reference£º
Article; Williams, John D.; Torhan, Matthew C.; Neelagiri, Venugopal R.; Brown, Carson; Bowlin, Nicholas O.; Di, Ming; McCarthy, Courtney T.; Aiello, Daniel; Peet, Norton P.; Bowlin, Terry L.; Moir, Donald T.; Bioorganic and Medicinal Chemistry; vol. 23; 5; (2015); p. 1027 – 1043;,
Indole alkaloid derivatives as building blocks of natural products from?Bacillus thuringiensis?and?Bacillus velezensis?and their antibacterial and antifungal activity study
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

3468-17-5, (1H-Indol-6-yl)methanamine is a indole-building-block compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example 76: Preparation of N-((lH-indol-6-yl)methyl)-5-(4-((2-oxopyridin-l(2H)- yl)methyl)benzyl)nicotinamide A mixture of 5-(4-((2-oxopyridin-l(2H)-yl)methyl)benzyl)nicotinic acid (91 mg, 0.28 mmol, 1.0 eq.), (1H- indol-6-yl)methanamine (44 mg, 0.30 mmol, 1.07 eq.), HATU (114 mg, 0.3 mmol, 1.07 eq.) and DIPEA (0.5 mL) in DCM (3 mL) was stirred at rt overnight. Filtered and the solid was collected and triturated with water to afford N-((lH-indol-6-yl)methyl)-5-(4-((2-oxopyridin-l(2H)-yl)methyl)benzyl)nicotinamide as a white solid (100 mg, 78.7%). LRMS (M+H+) m/z calculated 449.2, found 449.2. NMR (CD3OD, 400 MHz) delta 8.85 (s, 1 H), 8.57 (s, 1 H), 8.09 (s, 1 H), 7.69 (d, 1 H), 7.55-7.51 (m, 2 H), 7.39 (t, 1 H), 7.29-7.22 (m, 5 H), 7.03 (d, 1 H), 6.57 (d, 1 H), 6.43-6.37 (m, 2 H), 5.18 (s, 2 H), 4.67 (s, 2 H), 4.08 (s, 2 H).

3468-17-5, As the paragraph descriping shows that 3468-17-5 is playing an increasingly important role.

Reference£º
Patent; LIFESCI PHARMACEUTICALS, INC.; MCDONALD, Andrew; WO2015/103317; (2015); A1;,
Indole alkaloid derivatives as building blocks of natural products from?Bacillus thuringiensis?and?Bacillus velezensis?and their antibacterial and antifungal activity study
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles